Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Differential Effect of Neuropeptides on Excitatory Synaptic Transmission in Human Epileptic Hippocampus

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cortical and Subcortical Effects of Transcutaneous Spinal Cord Stimulation in Humans with Tetraplegia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effects of sensorineural hearing loss on cortical synchronization to competing speech during selective attention

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Differences in frontal network anatomy across primate species

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Parkinson patients have a presynaptic serotonergic deficit: A dynamic deep brain stimulation PET study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. A high-resolution in vivo atlas of the human brain's benzodiazepine binding site of GABAA receptors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Marco Ledri
  • Andreas T Sørensen
  • Marita G Madsen
  • Søren H Christiansen
  • Litsa Nikitidou Ledri
  • Alessandra Cifra
  • Johan Bengzon
  • Eva Lindberg
  • Lars H Pinborg
  • Bo Jespersen
  • Casper R Gøtzsche
  • David P D Woldbye
  • My Andersson
  • Merab Kokaia
Vis graf over relationer

Development of novel disease-modifying treatment strategies for neurological disorders, which at present have no cure, represents a major challenge for today's neurology. Translation of findings from animal models to humans represents an unresolved gap in most of the preclinical studies. Gene therapy is an evolving innovative approach that may prove useful for clinical applications. In animal models of temporal lobe epilepsy (TLE), gene therapy treatments based on viral vectors encoding NPY or galanin have been shown to effectively suppress seizures. However, how this translates to human TLE remains unknown. A unique possibility to validate these animal studies is provided by a surgical therapeutic approach, whereby resected epileptic tissue from temporal lobes of pharmacoresistant patients are available for neurophysiological studies in vitro. To test whether NPY and galanin have antiepileptic actions in human epileptic tissue as well, we applied these neuropeptides directly to human hippocampal slices in vitro. NPY strongly decreased stimulation-induced EPSPs in dentate gyrus and CA1 (up to 30 and 55%, respectively) via Y2 receptors, while galanin had no significant effect. Receptor autoradiographic binding revealed the presence of both NPY and galanin receptors, while functional receptor binding was only detected for NPY, suggesting that galanin receptor signaling may be impaired. These results underline the importance of validating findings from animal studies in human brain tissue, and advocate for NPY as a more appropriate candidate than galanin for future gene therapy trials in pharmacoresistant TLE patients.

OriginalsprogEngelsk
TidsskriftThe Journal of Neuroscience : the official journal of the Society for Neuroscience
Vol/bind35
Udgave nummer26
Sider (fra-til)9622-31
Antal sider10
ISSN0270-6474
DOI
StatusUdgivet - 1 jul. 2015

ID: 45644108